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Background: Cancer cells, and a variety of normal cells, exhibit aerobic glycolysis, high rates of glucose
fermentation in the presence of normal oxygen concentrations, also known as the Warburg effect. This metabolism
is considered abnormal because it violates the standard model of cellular energy production that assumes glucose
metabolism is predominantly governed by oxygen concentrations and, therefore, fermentative glycolysis is an
emergency back-up for periods of hypoxia. Though several hypotheses have been proposed for the origin of
aerobic glycolysis, its biological basis in cancer and normal cells is still not well understood.
Results: We examined changes in glucose metabolism following perturbations in membrane activity in different
normal and tumor cell lines and found that inhibition or activation of pumps on the cell membrane led to
reduction or increase in glycolysis, respectively, while oxidative phosphorylation remained unchanged.
Computational simulations demonstrated that these findings are consistent with a new model of normal
physiological cellular metabolism in which efficient mitochondrial oxidative phosphorylation supplies chronic
energy demand primarily for macromolecule synthesis and glycolysis is necessary to supply rapid energy demands
primarily to support membrane pumps. A specific model prediction was that the spatial distribution of
ATP-producing enzymes in the glycolytic pathway must be primarily localized adjacent to the cell membrane, while
mitochondria should be predominantly peri-nuclear. The predictions were confirmed experimentally.
Conclusions: Our results show that glycolytic metabolism serves a critical physiological function under normoxic
conditions by responding to rapid energetic demand, mainly from membrane transport activities, even in the
presence of oxygen. This supports a new model for glucose metabolism in which glycolysis and oxidative
phosphorylation supply different types of energy demand. Cells use efficient but slow-responding aerobic metabolism
to meet baseline, steady energy demand and glycolytic metabolism, which is inefficient but can rapidly increase
adenosine triphosphate (ATP) production, to meet short-timescale energy demands, mainly from membrane transport
activities. In this model, the origin of the Warburg effect in cancer cells and aerobic glycolysis in general represents a
normal physiological function due to enhanced energy demand for membrane transporters activity required for cell
division, growth, and migration.
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In 1867 Pasteur demonstrated that yeast decrease ethanol
production following aeration of the culture media [1]. This
observation has led to an enduring paradigm that in the
absence of pathology, glucose metabolism is predomin-
antly governed by oxygen concentrations. Thus, high-
efficiency oxidative phosphorylation (up to 36 ATP/glucose)
is generally assumed to be the default source of ATP under
normoxic conditions, whereas in the Emden-Meyerhoff fer-
mentative pathway, glycolysis (glucose metabolized to lac-
tate yielding 2 ATP/glucose), is an emergency back-up to
be used when oxygen is deficient [2]. Observed glucose me-
tabolism in most mammalian cells is consistent with this
Pasteur effect, although some lactate production is typically
observed even in the presence of oxygen [3-8]. Cancer cells,
on the other hand, typically exhibit high rates of glucose
fermentation in the presence of normal oxygen concentra-
tions (aerobic glycolysis). This phenomenon, also termed
the Warburg effect [9], has been recognized for nearly a
century.
Aerobic glycolysis is widely viewed as a ‘deregulation
of cellular energetics’ and thus, a hallmark [10] of can-
cer. However, decades of research to uncover the mo-
lecular source of abnormal cancer metabolism have
failed to identify a consistent etiology. It was originally
ascribed to a defect of oxidative metabolism [11], but
mitochondrial dysfunction is observed in only a small
subset of cancers [12,13]. Alternatively, it has been sug-
gested that the Warburg effect, through its production
of lactate, provides necessary carbon substrate for bio-
synthesis of macromolecules [14,15]. However, experimen-
tal observations [16] have demonstrated that only a very
small percentage of glucose carbons (<7%) is retained in
the cancer cell, while glutamine serves as the major source
for anabolic carbon and nitrogen.
Failure to identify a consistent pathological basis for aer-
obic glycolysis [17], even after several decades of investiga-
tion, led us to question the basic assumption that glucose
metabolism is governed solely by oxygen concentrations,
that is, aerobic glycolysis represents disordered cellular en-
ergetics only in the context of the standard paradigm of
oxygen-controlled ATP production. If one accepts the as-
sumption that glycolysis, because of its inefficiency in ATP
production, is used only when oxygen is inadequate then
glycolysis in normoxic conditions must be disordered.
Here we provide experimental and computational evi-
dence to support an alternative demand-driven model in
which glycolysis and oxidative phosphorylation are com-
plementary production modes that supply ATP to differ-
ent cellular processes with different timescales of energy
demands. In our model, cells exploit the efficiency of aer-
obic metabolism to meet baseline, steady-energy demand,
and the rapid response time of glycolysis is used to meet
short-timescale energy demands, mainly from membranetransport activities. This model of glucose metabolism re-
sembles the economic model of power-grid optimization.
As in power grids, the activity of each metabolic pathway
is governed by the magnitude of the energy demand that it
meets. For instance, the rate of glycolytic metabolism is
primarily determined by the activity of membrane trans-
port. As such, a chronic increase of glycolytic metabolism,
such as the Warburg effect in cancer, may be a physio-
logical response to increased energetic demand due to en-
hanced membrane transport activity required to cell
division, growth, and migration [18-21].
Methods
Cell culture
Cultures were maintained in standard incubation condi-
tions, 37°C and 5% CO2 culturing media as follows: HMEC
(Invitrogen Life Technologies Corporation, Carlsbad, CA,
USA) and HuMEC Basal Serum Free Medium (Invitrogen)
supplemented with HuMEC Supplement and Bovine Pituit-
ary Extract (Invitrogen); MCF10a (ATCC, Manassas, VA,
USA) and Dulbecco's modified Eagle's medium (DMEM)-
F12 (Invitrogen) and 5% HS (HyClone Laboratories, UT,
US); MCF7 (ATCC) and RPMI1640 (Invitrogen) + 10% FBS
(HyClone Laboratories); MDA-MB-231 (ATCC, 2007–
2010), DMEM-F12 (Invitrogen) and 10% FBS (HyClone La-
boratories); MCF7/DOX: detailed description of culturing
and cloning procedures can be found in a previous publica-
tion [22].
Immunofluorescence staining
HMEC cultured on collagen-coated 1.5 coverslips for
24 hours were washed with 3X PBS, fixed in 4% parafor-
maldehyde for 10 minutes, permeabilized in 0.1% Triton
for 10 minutes, and blocked in 1% BSA/1X PBS for 30 mi-
nutes. After washing cells in 3X PBS, they were serially in-
cubated in Anti-Pyruvate Kinase antibody (1:500, Abcam,
MA, US, ab6191), Goat antibodies were conjugated to a
secondary Alexa 488 antibody 1:500. The coverslips were
then mounted on microscope slides using Vectashild
(Vector Laboratories, Burlingame, CA, USA) containing
4',6-diamidino-2-phenylindole (DAPI) for nuclei staining.
Images were captured with a Leica TCS SP5 (Leica Micro-
systems Germany) confocal microscope.
Mitochondrial staining
HMEC cells were seeded in 35-mm glass bottom plates
(50 K cells/mL). They were incubated at 37°C/5% CO2
for 24 hours and then incubated with 0.5 mg/mL Mito
Tracker Green for 15 minutes and washed with 1X PBS.
Media were replaced prior to imaging.
Microscopy
Micrographs of HMEC cells in glass-bottom plates or
coverslips were taken with a Leica TCS SP5 AOBS laser
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Apochromat oil immersion objective lens (Leica Microsys-
tems). A 405-nm diode laser line was applied to excite
DAPI nuclear dyes, an Argon (Lasos, Germany) 488-nm
laser was used to excite Mito Tracker Green and Alexa 488
antibodies.
Metabolic profiling of membrane activity
Metabolic profiling was conducted using the Seahorse
XF reader (Seahorse Bioscience, Chicopee, MA, USA).
Cells were seeded in XF 96-well cell culture microplates
(Seahorse) at 12.5 × 103 cells/well (0.32 cm2) in 80 μL
growth medium, left at room temperature for 45 minutes
and then incubated at 37°C/5% CO2 for 20 to 24 hours.
Assays were initiated by removing the growth medium
from each well and replacing it with 180 μL basic non-
buffered media (see below), supplemented with glutam-
ine 2 mM glutamine, 0.5 mM pyruvate and 17.5 mM
glucose, washed three times by replacing 100 μL of the
media and then were incubated at 37°C with no CO2 for
45 minutes, to equilibrate. After calibration and equilibra-
tion measurements of oxygen consumption rate (OCR)
and proton production rate (PPR) were taken simultan-
eously in intervals of 6 minutes that included 2 minutes
mixing and 4 minutes of measurements. The values of
OCR and PPR reflect the activities of aerobic respiration
and glycolysis respectively. The experimental protocol con-
sisted of six basal measurements, followed by the reagent
injection at different concentrations (six wells for every
concentration) and additional hours of measurements, ex-
cept for Verapamil where the post-injection measurements
were 2 hours.
Ouabain and Verapamil (Sigma-Aldrich, O3125 and
1711202, MO, US) were dissolved in the non-buffered
media. Gramicidin A (Sigma-Aldrich, 50845) was first dis-
solved in DMSO (7.52 mg in 100 μL) and then added to a
non-buffered emulsion supplemented with Antifoam B
(1:100 v/v, Sigma-Aldrich, A5757) to improve solubility.
Seahorse non-buffered DMEM media were as follows:
8.3 g/L Standard DMEM Powder (Sigma-Aldrich); 1.85 g/L
NaCl; and 15 mg/L Phenol Red. Change in PPR and OCR
were calculated as:
Rate t0þt0ð Þ




where Rate (t) is the rate at time t before injection,
Ratec = 0(t) is the control rate (concentration = 0), t0
is the last point before injection and t’ is defined for
each reagent; Gramicidin A, the time of maximum PPR
for concentration of 20 μM, HMEC 40.8 minutes,
MCF10a 40.8 minutes, MCF7 37 minutes, MDA-MB-
231 27.2 minutes; Verapamil 116 minutes; Ouabain20.4 minutes for both HMEC and MDA-MB-231 cells;
and Mannitol 12 minutes.
Engineered cell lines and PMA-1 construct
Yeast plasma membrane ATPase 1 (PMA1 [NM:00118
0873]) was cloned into pcDNA3.1 vector (it is named here
pcDNA/PMA1). The details of the cloning will be shown in
an upcoming paper. MCF7 cells as the transfection host cell
line were acquired from American Type Culture Collection
(ATCC HTB-22, Manassas, VA, 20108) and were cultured
under standard cell culture conditions. The cells transfected
with pcDNA or pcDNA/PMA1 vectors, respectively, re-
sulted in MCF7/Mock and MCF7/PMA1 cell lines by a
standard stable cell construction procedure.
Western blotting
The cell membrane protein samples from the cultured
MCF7/Mock and MCF7/PMA1 cells were collected using
mem-per eukaryotic membrane protein extraction reagent
kit (Thermo Scientific, MA, US 89826) according to the
protocol instruction, and the protein samples were further
purified and concentrated by pierce SDS-PAGE sample
prep kit (Thermo scientific, 89888). Thirty micrograms
of protein per sample was separated on polyacrylamide-
SDS gels and electrophoretically transferred to nitrocel-
lulose membranes. Membranes were incubated with
primary antibody against PMA1 (1:1,000, Abcam, ab4645),
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(1:1,000, Santa Cruz Biotechnology, TX, US se-25778). For
visualization, horseradish peroxiase (HRP)-conjugated sec-
ondary antibodies: Goat anti-rabbit IgG HRP and goat
anti-mouse IgG HRP, followed by the ECL kit (Thermo
Scientific, 32209) were used.
Oxygen consumption and proton production
rate measurements
OCR and PPR for MCF7, MCF7/Mock and MCF7/
PMA1/Clone 1 cells were measured by using the Seahorse
Extracellular Flux (XF-96) analyzer (Seahorse Bioscience).
The cells were cultured for one hour in the absence of glu-
cose in a non-CO2 incubator prior to the measurements.
Then the PPR and OCR were measured in the absence of
glucose associated with non-glycolytic activity, following
three sequential injections of D-glucose (5 mM), oligomy-
cin (1 μM), and 2-deoxyglucose (50 mM) in real time.
Glycolytic PPR was determined by the difference between
the PPR in the presence of glucose and in the absence of
glucose. Protein concentration was determined for each
well using a standard BCA protein assay. The OCR and
PPR values are normalized to μg protein.
Statistical analysis
For metabolic profiling of membrane activity (Figures 1
and 2), each reagent concentration was measured six
Figure 1 Changes in proton production rates, indicating glycolytic activity, and oxygen consumption rates, corresponding to oxidative
phosphorylation, following stimulation/inhibition of membrane transporters. Changes in proton production rates are represented by
red diamonds and oxygen consumption rates by blue circles. (A) Stimulation of Na+/K+-ATPase through increasing concentration of Na+/K+-ionophore
Gramacidin A in normal human mammary epithelial cells (HMEC), and in dysplastic (MCF10A), non-metastatic (MCF7) and invasive, malignant
(MDA-mb-231) cells results in increasing glycolytic activity and little change in oxidative phosphorylation except for a decline at the highest
dose. (B) Stimulation of P-glycoprotein (PGP) pumps on the membrane of PGP-expressing MCF7 cells by Verapamil also results in increase of
glycolytic activity. (C) Inhibition of membrane activity by increasing concentrations of Ouabain in both malignant (MDA-mb-231) and normal
(HMEC) cells results in a decrease in glycolytic rates but no significant change in oxidative metabolism. Error bars represent SD (n = 6).
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filing of PMA1-transfected cells (Figure 3), every measure-
ment was repeated four times; the error bars demonstrate
SD. The two-tailed Student t-test was used to calculate
statistical significance.Computational modeling
For detailed description on computational modeling, see
Additional file 1.Figure 2 Metabolic profiling of osmotic stress. Relative changes in
proton production rates (red diamonds) indicating glycolytic activity, and
oxygen consumption rates (blue circles) corresponding to oxidative
phosphorylation, following an increase in extracellular osmotic pressure
using mannitol. For both human mammary epithelial cells (HMEC)
and MDA-MB-231, glycolysis is the main energetic source for
osmotic balancing across the plasma membrane. Error bars
represent SD (n = 12).Results
To investigate the separation of energy demand and pro-
duction, we examined changes in glucose metabolism fol-
lowing perturbations in membrane transport activity under
normoxic conditions in several cell lines, which represent
the spectrum from normal breast epithelium to aggressive,
metastatic cancer. We measured changes in OCR and
glucose-dependent PPR, which indicate changes in rates of
oxidative and glycolytic metabolism respectively. As dem-
onstrated in Figure 1, the Na+/K+-ionophore Gramicidin A
was added to culture media to increase Na+/K+-ATPase ac-
tivity by disrupting the ionic balance. This led to significant
increases in the glucose-dependent proton production rate,
indicating upregulated glycolysis, while oxygen consump-
tion rates were reduced or unchanged (Figure 1A). Similar
results were obtained with the activation of P-glycoprotein
(PGP) transporters, which pump lipophilic cationic xenobi-
otics out of cells, in PGP over-expressing MCF7 cells fol-
lowing addition of a substrate (Verapamil) to the culture
medium (Figure 1B). In contrast, Ouabain was used to in-
hibit Na+/K+-ATPase in normal breast epithelial (HMEC)
and breast cancer (MDA-MB-231) cells, and this led to sig-
nificant decreases in glucose-dependent acid production
while the oxygen consumption rates were not significantly
affected (Figure 1C).
We also measured changes in glucose metabolism in
response to acute osmotic stress, which increases the
Figure 3 Metabolic profile of adaptation to chronic increase of membrane transporter activity using plasma membrane ATPase 1
(PMA1)-cloned MCF7. The proton production rate (PPR) and oxygen consumption rate (OCR) were measured in the indicated cell lines.
(A) Basal, non-glycolytic, PPR, indicating H+ pump activity is significantly higher in the PMA1 clone compared to control cells MCF7 or mock
(measured in the absence of glucose). (B) Glycolytic PPR was significantly higher in the PMA1 clone (2.1-fold, compared to control cells MCF7 or
mock-transfected cells) but (C) there was no significant change in OCR. The data represent the mean ± standard error from three individual
experiments. The two-tailed Student t-test was used to calculate statistical significance: *P <0.05; error bars represent SD (n = 4).
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motic shrinkage [23-25]. Addition of mannitol to the
media, both in normal breast epithelial (HMEC) and breast
cancer (MDA-MB-231) cells led to an increase in glycolytic,
compared to oxidative, metabolism (Figure 2). It is similarly
notable that manipulations of macromolecule synthesis
processes have been reported to affect respiration but not
glycolysis [26].
These results were consistent with computational simu-
lations of changes in short-timescale demand for energy
by cell membrane processes (Figure 4A). In these simula-
tions (supplemental Algorithm 1 in Additional file 1), we
imposed periodic and acute energy demands (black bar),
which we allowed to be satisfied by slow/efficient (blue)
and rapid/inefficient (red) ATP generating processes. As
shown here, there were large and significant increases in
the rapidly responding (glycolytic) mechanism, with onlyFigure 4 Simulations of periodic intervals of an increased demand fo
1D cell (Additional file 1: Figure S2). (A) Top: periodic ATP demand; mid
(blue) and glycolytic ATP production (red). (B) Total ATP production rate of
rate (blue circles) at different pulse frequencies, where frequency incremen
While glycolytic production rate is highly dependent on the demand frequ
similar to the experimental results shown in Figure 2.slight changes in the slow (mitochondrial) mechanism
(Figure 4B).
In addition, we examined the metabolic consequences of
adaptation to chronic increase of membrane transporter
activity without external perturbation using cloned MCF7
cells transfected with yeast plasma membrane ATPase,
(PMA-1) [27]. Under normoxic conditions, PMA-1-
transfected cells exported protons at approximately
150% the rate of mock transfectants or parental cells
(Figure 3A), with the majority of energy for this process
being supplied by greater than 2-fold increase in
glucose-dependent proton production (Figure 3B), which
is in contrast to the absence of differences in respiration
rates (Figure 3C). This suggests that the increased reli-
ance on glycolysis appears to be associated with energy
demand at the membrane, even under chronic condi-
tions. Nonetheless, we contend that this association hasr ATP, at the region within 1 μm from the cell membrane, on a
dle: ATP level (green line); bottom: mitochondrial ATP production
the glycolytic pathway (red triangles) and mitochondrial respiration
t/reduction represent activation/inhibition of membrane demand.
ency, mitochondrial production rate remains relatively constant,
Figure 5 Compartmentation of metabolic pathways in different
sites in the cell. (A) Simulation results demonstrating the decline of
ATP due to a step-wise increase in demand at the cell membrane
depending on the localization of the ATP-producing enzymes in the
glycolytic pathway. To maintain the ATP concentration above the
90% threshold observed experimentally, the simulations demonstrate
the source of ATP production must be concentrated next to the cell
membrane. Immunocytochemical images of (B) pyruvate kinase,
(C) phosphoglycerate kinase, (D) glyceraldehyde 3-phosphate
dehydrogenase and (E) mitochondria in HMEC cells, demonstrating
distinctive peripheral and distinct perinuclear distribution of the
pathways respectively (blue, nuclei staining).
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sponse time afforded by glucose fermentation.
The different timescales of ATP-demand influence the
spatial localization of the metabolic pathways. That is,
ATP-producing enzymes in the glycolytic pathway must be
localized near the plasma membrane (PM) to permit rapid
supply of ATP directly to membrane pumps. Numerical
simulations of a sudden increase in energy demand at the
PM demonstrate that maintaining ATP concentration
above 90% [28] requires localization of the rapid ATP-
producing processes in the vicinity of the PM (Figure 5A).
The numerical prediction that the two metabolic pathways
are spatially separated is consistent with immunocyto-
chemical imaging of the glycolytic enzyme, pyruvate kinase
(Figure 5B), glyceraldehyde 3-phosphate dehydrogenase
(Figure 5C) and phosphoglycerate kinase (Figure 5D), in
HMEC cells indicate that their spatial distribution is in the
periphery of the cytoplasm, adjacent to the PM. In contrast,
mitochondria in HMEC cells are perinuclear (Figure 5E).
Discussion
Our results demonstrate that glycolysis serves a critical
physiological function in normoxic conditions by respond-
ing to rapid energetic demands that occur primarily in the
cell membrane. We showed that inhibition or activation of
transporters on the cell membrane led to reduction or in-
crease in glycolytic activity, respectively, while the respir-
ation rate remained unchanged. Furthermore, increased
aerobic glycolysis is also observed in chronically increased
membrane demand in cells with constitutively upregulated
membrane pumps. Interestingly, this suggests that while in-
creased acid export into the environment may be a conse-
quence of upregulation of aerobic glycolysis, it may also be
a cause.
In all of our experiments, we did not observe significant
changes in OCR following membrane transporters manipu-
lations. Therefore, regardless of additional processes that
might influence the PPR measurements, manipulations of
the energetic demands of the membrane transporters led to
changes in glycolytic metabolism. Consistent with model
prediction we showed that the spatial distribution of ATP-
producing components of glycolysis (pyruvate kinase),
rather than well-mixed in the cytoplasm, are primarily
localized adjacent to the cell membrane, while mitochon-
dria, responsible for aerobic metabolism, are typically peri-
nuclear in mammalian cells [29-31]. Prior studies have
similarly localized glycolytic metabolism adjacent to the
membrane in muscle cells [32] and erythrocytes [33] and it
has been suggested that this co-localization of the glycolytic
enzymes expedites the production of ATP by metabolic
channeling [34,35]. Interestingly, while the biochemical de-
tails of cellular glucose metabolism have been thoroughly
investigated for decades [36-38], the spatial constraints on
these complex dynamics are rarely considered [39].These results support an alternative, demand-based
model of glucose metabolism, in which oxidative and fer-
mentative metabolic pathways are complementary pro-
duction modes that supply ATP for slowly responding
basal demand and rapidly responding peak demand, re-
spectively (Figure 6). Power grids provide a useful analogy.
Economic analyses of strategies to minimize the total cost
of power generation while satisfying variable real-time













Figure 6 Proposed metabolic model. Glycolysis supplies energy
for membrane components such as ion transporters and oxidative
metabolism primarily supplies energy for macromolecule synthesis.
(PER – Phosphoenolpyruvate; PYR – Pyruvate).
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peak-load components [40] (Figure 7). Base load is the con-
tinuous energy demand of the system. Peak loads are the
fluctuating component in energy demand superimposed on
the base-load demand. The former is satisfied by coal or
nuclear plants, which are efficient but slow to respond,
whereas the latter is typically met by less efficient but fast-
responding gas turbines. Thus, measurement of nuclear or
coal power generation reflects the base demand of an elec-
tric grid and the activity of gas turbines is determined by
the magnitude of fluctuating peak demand.
Similar to power grid economics, cells maintain the low-
est possible baseline ATP production rates but with re-
serve production capability sufficient for rapid response to
















Figure 7 Load curve diagram showing power demand over a
course of time. In optimal design of power grids, power demand is
typically divided into base-load demand (blue), which is the continuous
basal demand of power, and peak-load (red), short periods of an
increased demand for energy. Different power plants with different
efficiency and response time supply the two types of demands.metabolism, oxidative phosphorylation supplies stable or
slowly fluctuating demands with highly efficient conver-
sion of carbons to CO2 and ATP. The penalty for high effi-
ciency, however, is slow response to transient increases in
demand. Mitochondrial respiration requires about 12 to
13 seconds [41-43] to respond to sudden changes in cell
function or external perturbations, which, though fast, may
be insufficient for critical processes. In contrast, the glyco-
lytic pathway, although less efficient, can accelerate ATP
production within milliseconds to provide ATP following
high-amplitude or high-frequency increases in demand
[44]. We do not dispute the importance of the Pasteur ef-
fect. Of necessity cells must switch to glycolysis in hypoxic
conditions, but this does not mean that glycolysis serves no
role in aerobic conditions. Returning to our power grid ana-
logy, gas turbines supply energy for fluctuating energy and
serve as back-up should base-load production fail. Similarly,
in normal physiological conditions, glycolytic metabolism is
maintained and its magnitude is governed by fluctuations
in the energy demand primarily for membrane activity.
High frequency fluctuations in energy demand occur
most commonly at the cell membrane, primarily for main-
taining local osmotic balance across the cell membrane by
energy-dependent water and ion fluxes. Failure of effective
and rapid response to local changes in the osmotic balance
across the cell membrane may result in unregulated mem-
brane protrusion or impairment of membrane integrity; po-
tentially causing lethal cell damage. Thus, the fast response
of the glycolytic pathway serves a critical role, by respond-
ing to rapid fluctuations in energy demand [45-48] when
oxidative phosphorylation may be insufficient to maintain
the adequate levels of ATP necessary to permit cell survival
following environmental fluctuation, or support rapid and
diverse membrane changes required for cell movement.
In our model of glucose metabolism, glycolysis will be
increased by any cellular processes that activate mem-
brane pump activity, including changes in cell shape such
as mitotic rounding [18], invasion through confined spaces
[19], and motility [20,21]. Consistent with this, aerobic gly-
colysis is observed in numerous physiological processes
that are associated with acute membrane events such as
lymphocyte proliferation and antibody secretion [3,7],
macrophages migration [8], embryonic cytokinesis and cell
migration [4].
Furthermore, increased aerobic glycolysis in cancer cells
may originate simply as a physiological response to in-
creased fluctuations in energy demand due to enhanced
membrane transporter activity [49], which is necessary for
virtually every critical malignant phenotypic property [10]
including proliferation, growth, migration and invasion,
and requires increased membrane activity. Interestingly,
Racker observed increased glycolysis following activation
of the Na+/K+-ATPase [50] over 40 years ago and pro-
posed that the Warburg effect was caused by a defect in
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ciently. However, this mechanism was unsubstantiated
[51,52]. Our model, in contrast, proposes that aerobic gly-
colysis is not a disorder of metabolism but simply the
physiological response to fluctuating energy demands
within the membrane due to normal but upregulated ac-
tivity of transporters required for cell division, growth, and
migration.
We recognize that, regardless of the mechanism of its
origin, increased aerobic glycolysis may lead to a
broader dysregulation of cellular energetics during can-
cer evolution because it confers an additional selective
advantage [53]. For example, increased glycolytic metabol-
ism leads to increased production of hydrogen ions, which
in combination with insufficient blood perfusion induce an
acidic extracellular environment, which may promote inva-
sion, and further the membrane energy demand in a vicious
cycle [53-55]. In addition, It has been known since the early
20th century [56] that pyruvate can be an efficient scavenger
of reactive oxygen species [57,58] and thus, the pyruvate
generated by glycolytic metabolism will protect cells from
oxidative stress, especially prior to the S phase [59,60].
Conclusion
In conclusion, we introduce a model wherein energy me-
tabolism is primarily governed by the temporal dynamics
of energy demand, and not by the availability of oxygen.
We do not dispute the importance of the Pasteur effect,
glycolysis is a necessary emergency back-up that permits
cells to adapt to periods of hypoxia. We propose, however,
that the converse is not true - cells use glycolysis even in
the presence of oxygen to respond to fluctuating energy
demands primarily in the membrane. In our model, the
Warburg effect in cancer cells originates not as a disorder
of cellular energetics but as a physiological response to
meet energy from membrane activity in mobile, prolifera-
tive cells particularly in a temporally and spatially variable
environment.Additional file
Additional file 1: Computational modeling. Description of data:
description of numerical model including model equations, detailed
simulation results and a Matlab code.Abbreviations
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